Tag: Eisai
Biogen Explodes on Game-Changing Alzheimer’s News
Shares of Biogen (BBIB) are up more than $93 in pre-market.
All after a substantial announcement on its Alzheimer’s drug study, in partnership with Eisai.
In...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
*by submitting your information you agree to the terms of our Privacy Policy. You will receive FWeekly Stock Watch email and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.